Xeptiva Therapeutics

  • Home
  • Company
    • About us
    • Team
  • Innovation
    • Technology
    • Pipeline
    • Target diseases
  • News
    • See news
    • Press releases
  • Blog
  • Contact
  • Home
  • Company
    • About us
    • Team
  • Innovation
    • Technology
    • Pipeline
    • Target diseases
  • News
    • See news
    • Press releases
  • Blog
  • Contact

PIPELINE

PRODUCTS IN DEVELOPMENT

We're developing therapies to improve companion animal's health.  
G
​Target identification
​Preclinical Studies
POC Clinical trial
Clinical Trial
Registration

XEP01

Xep02

Xep03

Xep04

Xep05

Dog oSTEOARTHTRITIS chronic pain

68%

Dog atopic dermatitis

64%

fELINE OSTEOARTHTRITIS CHRONIC PAIN

40%

fELINE ATOPIC SKIN SYNDROME

40%

DOG SENESCENSE

25%

learn more about our target diseases

TARGET DISEASES

COMPANY

About Us
Team

INNOVATION

Technology
Pipeline
Target diseases

NEWS

See News
Press releases

cONTACT

BLOG

© COPYRIGHT 2023. ALL RIGHTS RESERVED.